Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea
Mount Sinai Health SystemNew method can predict risks of cardiovascular disease, mortality in sleep apnea patients
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
A diagnostic test, first offered in the United States at University Hospitals Harrington Heart & Vascular Institute, has now shown through a clinical study to significantly decrease cardiovascular mortality, reduce additional non-invasive heart testing, and increase cath lab efficiency.
Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a significantly increased risk of ischemic stroke in a diverse group of U.S. adults, according to new research being presented at the 148th Annual Meeting of the American Neurological Association (ANA). Suffering more than one head injury further increased the risk.
FINDINGS UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality. But 10-year conditional survival was similar for biventricular and most single-ventricle CHD patients, and notably better for biventricular CHD patients compared to non-CHD heart transplant recipients.
Researchers at Washington University in St. Louis have developed a new computational approach to removing movement in images of expanding and contracting heart cells and tissues. By computationally removing movement, the algorithm mimics a drug’s action in stopping the heart, without compromising cellular structure or tissue contractility.
The University of Kentucky’s Vice President for Research and leading cardiovascular scientist is being recognized for her foundational work in the field of hypertension with a prestigious award from the American Heart Association (AHA).
A research team, affiliated with UNIST has achieved a groundbreaking milestone in tissue regeneration by developing a technology that utilizes autologous blood to produce three-dimensional microvascular implants.
The treadmill exercise test with electrocardiogram (ECG), also known as an exercise stress test, is one of the most familiar tests in medicine.
Although hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are eligible for high-intensity statin therapy, most are not using the drugs, UT Southwestern Medical Center researchers report.
Agreement aims to improve patient care and outcomes on a global scale
UC Davis and the University of Oxford researchers developed a new software tool, SparkMaster 2, that allows scientists to analyze normal and abnormal calcium activity in cells. Problems with how and when calcium is released by cells can have an impact on a range of diseases, including arrhythmia and hypertension.
Los investigadores de Cedars-Sinai son líderes en la innovación y el uso del reemplazo valvular aórtico transcatéter (TAVR) con válvulas expandibles con balón. Ahora demuestran que volver a hacer los procedimientos TAVR son seguros y eficaces en comparación con situaciones en las que pacientes con perfiles de riesgo similares se someten al mismo procedimiento por primera vez.
The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
FINDINGS People from socioeconomically distressed communities who underwent heart transplantation between 2004 and 2018 faced a 10% greater relative risk of experiencing graft failure and dying within five years compared to people from non-distressed communities. In addition, following implementation of the 2018 UNOS Heart Allocation policy, transplant recipients between 2018 and 2022 faced an approximately 20% increase in relative risk of dying or experiencing graft failure within three years compared with the pre-policy period.
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
A Binghamton University, State University of New York researcher will lend his data-analysis skills to a landmark study of Latina women funded by the National Institutes of Health.
Despite advancements in care, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years – more often killing men, Black patients and those from rural areas.
People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared to people who also had an intracerebral hemorrhage but were not taking statins, according to a new study published in the August 30, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Your daily dose of omega-3s may not be doing what you think it is. Most fish oil supplements on the market today have labels boasting health benefits that aren’t supported by clinical data, according to a study published in JAMA Cardiology by researchers at UT Southwestern Medical Center.
A study of more than 83,000 questionnaires by women ages 50-79, found more than 25% developed irregular heart rhythms, known as atrial fibrillation, which may increase their risk for stroke and heart failure.
New research from UChicago Medicine suggests parental incarceration elevates cardiovascular risk in early adulthood, potentially contributing to larger health disparities.
A multi-site, five-year study led by a MedStar Heart & Vascular Institute cardiologist and fellow researchers from across the country have demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM), a disease of the heart muscle and their at-risk family members.
Adults at risk for heart disease who participated in produce prescription programs for an average of six months increased their consumption of fruits and vegetables and had reduced blood pressure, body mass index and blood sugar levels.
CobiCure Medical Technologies, a non-profit pediatric initiative, part of the Advancium Health Network, announced today its continued commitment to solving the unmet needs in pediatric medical technologies.
Pooled analysis of nine produce prescription programs, which are designed to remove barriers to accessing fruits and vegetables to individuals with diet-related illness, found these programs were associated with positive health benefits, from halving food insecurity to lowering blood pressure.
A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University’s Victorian Heart Institute and Victorian Heart Hospital.
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
Investigators from the Smidt Heart Institute at Cedars-Sinai are one step closer to helping individuals catch a sudden cardiac arrest before it happens, thanks to a study published today in the peer-reviewed journal The Lancet Digital Health.
Results from a large-scale clinical trial could increase usage of high resolution imaging for guiding interventional coronary procedures
Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
Patients living with one of the UK’s most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found.
Dr. Yoon Ki Joung and Dr. Juro Lee of the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with Prof. Hun-Jun Park and Dr. Bong-Woo Park of the Catholic University of Korea College of Medicine, have developed a new treatment for myocardial infarction that uses nanovesicles derived from fibroblasts with induced apoptosis to modulate the immune response.
John Chappell, a cardiovascular scientist in the Center for Vascular and Heart Research at the Fralin Biomedical Research Institute at VTC, didn't quite believe what he was seeing.
Throughout the European Society of Cardiology (ESC) Congress August 25-28, 2023, in Amsterdam, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiology, including some of the most recent and promising breakthroughs in research.
A pré-eclâmpsia, um aumento repentino na pressão arterial que representa risco para a vida, é um problema enigmático. A cada ano, ela causa a morte de mais de 70 mil mulheres ao redor do mundo. Como os cientistas não sabem qual é a causa dessa condição, não há estratégias específicas para tratá-la.
UK households that grow their own fruits and vegetables can improve their diet, reduce waste, and help to increase national food self-sufficiency.
La preeclampsia, que es un aumento de la presión arterial que pone en riesgo la vida, es una afección enigmática. Cada año, causa la muerte de más de 70 000 mujeres en todo el mundo. Dado que los científicos no conocen sus causas, carecen de estrategias específicas para tratarla.
Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at Washington University School of Medicine in St. Louis.
An analysis of more than 45,000 people infected with SARS-CoV-2 found a significant association between the virus and the development of persistent high blood pressure among those with no prior history of high blood pressure.
Clopidogrel is a commonly prescribed medication used to prevent further heart attacks after an initial event. It needs to be activated in the body to be effective.
What if we could identify the earliest warning signs of cardiovascular disease from a simple saliva sample? Scientists think they have found a way to do so. Gum inflammation leads to periodontitis, which is linked with cardiovascular disease.
E. Dale Abel, MD, PhD, chair of the Department of Medicine at the David Geffen School of Medicine at UCLA and executive medical director of the UCLA Health Department of Medicine has received the Endocrine Society Fred Conrad Koch Lifetime Achievement Award, the group’s highest honor, recognizing exceptional contributions to the field of endocrinology.
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
Parents can be so protective of a child with congenital heart disease they often forget what comes next. When should they start learning to take care of their own condition? Two Penn State Health experts share their views.
Pain one year following a heart attack is common and linked with a higher likelihood of death within the next 8 years, finds new study in the Journal of the American Heart Association.